Get the Stockscreener App
23.03
0.39%
0.09
After Hours:
22.81
-0.22
-0.96%
Avadel Pharmaceuticals Plc stock is traded at $23.03, with a volume of 2.72M.
It is up +0.39% in the last 24 hours and up +28.88% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$22.94
Open:
$22.76
24h Volume:
2.72M
Relative Volume:
1.00
Market Cap:
$2.25B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
-697.88
EPS:
-0.033
Net Cash Flow:
$5.89M
1W Performance:
-2.25%
1M Performance:
+28.88%
6M Performance:
+151.69%
1Y Performance:
+97.51%
1-Day Range:
$22.72
$23.08
1-Week Range:
$22.72
$23.36
52-Week Range:
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
10 EARLSFORT TERRACE, DUBLIN 2
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
23.03 | 2.25B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
BlackRock discloses 6.68% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Citadel discloses 2.21% stake in Avadel Pharmaceuticals - Investing.com India
TIG Advisors discloses 2.98% stake in Avadel Pharmaceuticals - Investing.com India
BlackRock discloses 6.68% stake in Avadel Pharmaceuticals - Investing.com India
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com India
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com India
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Citadel Group discloses 2.09% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal - Yahoo Finance
Bank of America discloses 3% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading activity in Avadel Pharmaceuticals - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Is Avadel Pharmaceuticals plc stock attractive for ETFsWeekly Stock Recap & Stepwise Trade Signal Guides - newser.com
Is Avadel Pharmaceuticals plc (AWK) stock a buy before new product rolloutWeekly Trade Report & Weekly Hot Stock Watchlists - newser.com
Can Avadel Pharmaceuticals plc stock maintain growth trajectoryTrade Risk Report & AI Driven Stock Reports - newser.com
What dividend safety rating applies to Avadel Pharmaceuticals plc (AWK) stock2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
How Avadel Pharmaceuticals plc (AWK) stock moves in volatile trading sessionsEarnings Growth Summary & Fast Exit/Entry Strategy Plans - newser.com
Is Avadel Pharmaceuticals plc (AWK) stock prepared for digital transitionBuy Signal & Low Risk High Reward Ideas - newser.com
Is Avadel Pharmaceuticals plc stock a safe haven assetJuly 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com
How Avadel Pharmaceuticals plc (AWK) stock compares with top peers2025 Key Lessons & Safe Investment Capital Preservation Plans - newser.com
Alkermes Fires Back In Bidding War With Lundbeck Over Avadel - Citeline News & Insights
Alkermes, Avadel Bump Deal To $2.37B After Alternate Bid - Law360
Avadel Pharmaceuticals agrees to sweetened $2.37B takeover bid from Alkermes amid bidding war - The Business Journals
Morgan Stanley Capital Services discloses dealings in Avadel shares By Investing.com - Investing.com Nigeria
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-DENN, ELST, AVDL, and CADE - Benzinga
Applying chart zones and confluence areas to Avadel Pharmaceuticals plcQuarterly Trade Review & Real-Time Volume Surge Alerts - newser.com
Statistical indicators supporting Avadel Pharmaceuticals plc’s strengthPortfolio Risk Summary & Stock Market Timing Techniques - newser.com
Kevin Kotler discloses 1.86% stake in Avadel Pharmaceuticals - Investing.com
Avadel board backs Alkermes' higher offer over Lundbeck proposal - Reuters
Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer - PharmExec.com
Alkermes Faces Bidding Battle For Avadel Pharmaceuticals - Finimize
How Avadel Pharmaceuticals plc (AWK) stock reacts to stronger dollarMarket Movers & Low Drawdown Momentum Ideas - newser.com
How interest rate cuts could boost Avadel Pharmaceuticals plc stockJuly 2025 Gainers & Pattern Based Trade Signal System - newser.com
Goldman Sachs discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
How Avadel Pharmaceuticals plc (AWK) stock performs in volatility spikesWeekly Trend Summary & Daily Growth Stock Tips - newser.com
Bank of America discloses 3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Alkermes raises offer for Avadel acquisition and secures $1.5 billion loan facility - Investing.com Australia
Alkermes Increases Offer for Avadel Acquisition - TipRanks
Avadel Pharmaceuticals Amends Agreement with Alkermes - TipRanks
Alkermes increases offer for Avadel to $21 in cash plus CVR - Investing.com Canada
Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc - PR Newswire
Alkermes Increases Offer to Acquire Avadel - Sleep Review
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):